Laryngeal rare benign non-epithelial tumors and sarcomas emphasizing on chondrosarcomas: a literature review and a case presentation.

Laryngeal rare tumors include benign and malignant tumors of epithelial, non-epithelial, or mesenchymal origin. Chondrosarcomas are the most common mesenchymal malignant tumors of the larynx. We performed a literature review (Pubmed/Medline; PRISMA 2020) to detect the frequency of published studies from 2021 to April 2024 regarding benign and malignant epithelial, non-epithelial, or mesenchymal rare tumors of the larynx, emphasizing laryngeal chondrosarcoma (LC) cases. Articles including cases discussed before 2021 were excluded and articles without available English translations. We included 154 articles investigating rare tumors of the larynx, the majority of them discussed non-epithelial or mesenchymal entities (75%). Specifically, a high proportion of studies examined benign non-epithelial or mesenchymal tumors (79.5%) or mesenchymal rare malignancies (72%) of the larynx concerning epithelial tumors in the last three years. Sarcomas were discussed in 74% of mesenchymal laryngeal malignancies and more than 50% of rare laryngeal tumor studies, and LC was discussed in ~50% of laryngeal sarcoma studies. LC studies reported 174 cases, 21% of them of high-grade LC (II), including a new case of LC presented here in the supraglottic (grade II), which showed intense staining for the S100 marker. Our study highlights the awareness of rare laryngeal tumors emphasizing non-epithelial benign tumors and laryngeal sarcomas, including chondrosarcomas, as pathologic entities of the larynx. Although the majority of LC included low-grade neoplasms, a markedness proportion of LC cases was evaluated as high-grade. Future research approaches, including a range of low and high-grade tumors, would reveal prognostic markers or therapeutic targets for LC and other rare laryngeal malignancies of non-epithelial or mesenchymal origin.